Thank you to all who supported CHI's Ninth Annual Discovery on Target event!

Over 500 participants gathered at the historic Park Plaza Hotel & Towers in Boston, Massachusetts CHI's Discovery on Target event. From attendees, to exhibitors, speakers, and sponsors this year's conference was another great success for all involved.

Delegates enjoyed being able to create their own agenda by moving between the tracks and choosing the sessions that best fit their learning and networking needs.

The Exhibit Hall functions offered ample networking opportunities, and the perfect venue to launch new product and services.

Plan to join us again next year October 1-3, 2012 in Boston!

If you would like to share your feedback, or give input for next year's event please contact, Margit Eder at meder@healthtech.com.

November 2-3 

HDAC Inhibitors

GPCR-Based Drug Discovery

The Kinase Inhibitor Pipeline

Cancer Cell Metabolism 

November 3-4 

RNAi for Functional Screens

Allosteric Modulators

Targeting the P13K Pathway

Diabetes Drug Discovery 

EVENT FEATURES

● Co-Located: Ion Channel Symposium
● 130+ Scientific and Technical Presentations
● 500+ Participants
● Breakout Discussion Groups

● 30+ Exhibiting Companies
● 9 Interactive Short Courses
● Dedicated Poster Viewing

DOT Hub Icon 

 Short Courses


2015 Discovery on Target Brochure  

2015 BROCHURE


 PREMIER SPONSORS

Cellecta 

Domainex

Molecular Sensing

Rosa Drug Development Advisors

Sigma_NEW

VIEW ALL SPONSORS

VIEW MEDIA PARTNERS


IPR_Micrombiome


SPONSORSHIPS & EXHIBITS

The exhibit hall was sold out in 2014, so please contact us early to reserve your place. To customize your sponsorship or exhibit package for 2015, contact:

Jon Stroup
Sr. Business Development Manager
781-972-5483
jstroup@healthtech.com


 
 

September 21 

Next-Generation Histone Deacetylase Inhibitors Symposia 

Strategies for Rare Diseases Symposia 

September 22 

Developing CRISPR-Based Therapies Symposia 

September 22 - 23 

Targeting Epigenetic Readers and Chromatin Remodelers 

Targeting the Ubiquitin Proteasome System 

Targeting the Microbiome 

GPCR - Based Drug Discovery - Part 1 

Antibodies Against Membrane Protein Targets - Part 1 

RNAi for Functional Genomics Screening 

Gene Therapy Breakthroughs 

Targeting Ocular Disorders 

September 23 - 24 

Targeting Histone Methyltransferases and Demethylases 

Targeting the Unfolded Protein Response 

Kinase Inhibitor Discovery 

GPCR-Based Drug Discovery - Part 2 

Antibodies Against Membrane Protein Targets - Part 2 

New Frontiers in Gene Editing 

Quantitative Systems Pharmacology 

Short Courses 

SC1: Cancer Metabolism: Pathways, Targets and Clinical Updates 

SC2: Leveraging Data and Analytics for Drug DiSCovery 

SC3: Setting Up Effective Rnai SCreens: From Design to Data to Validation 

SC4: Phenotypic SCreening and Chemical Probe Development 

SC5: GPCR Structure-based Drug Discovery 

SC6: Targeting of GPCRs with Monoclonal Antibodies 

SC7: Setting Up Effective Functional SCreens Using 3D Cell Cultures 

SC8: Targeting Protein-protein Interactions: Biophysical Approaches 

SC9: Preclinical Animal Models for Ocular Indications 

SC10: Introduction to Allosteric Modulators and Biased Ligands of GPCRs 

SC11: Introduction to Targeted Covalent Inhibitors 

SC12: Assays and High-throughput SCreening for Novel Epigenetic Inhibitors 

SC13: Gamification and Drug Target Challenges 

SC14: A Primer to Gene Editing: Tools and Applications 

SC15: Using Mechanistic Physiological Models In Drug Development